<

NANOBIOTIX (EPA:NANO) Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy

Transparency directive : regulatory news

02/06/2024 16:00

source : webdisclosure.com



Other stories

07/12/2024 01:00
06/12/2024 23:10
06/12/2024 19:09
05/12/2024 14:52
06/12/2024 13:08
06/12/2024 22:08
06/12/2024 21:00
06/12/2024 18:20
06/12/2024 13:15
05/12/2024 09:00
06/12/2024 15:13
06/12/2024 15:23
06/12/2024 18:46
05/12/2024 21:48
06/12/2024 16:11
06/12/2024 17:38
06/12/2024 18:55
06/12/2024 09:39
06/12/2024 09:05
05/12/2024 17:19
06/12/2024 17:26
06/12/2024 16:06
07/12/2024 00:11
07/12/2024 01:50
06/12/2024 23:15
07/12/2024 03:27
07/12/2024 03:31
06/12/2024 23:31
06/12/2024 19:31
06/12/2024 23:46
06/12/2024 05:39
06/12/2024 00:02
06/12/2024 14:03
06/12/2024 15:54
07/12/2024 03:52
06/12/2024 19:00
06/12/2024 09:56
05/12/2024 14:17